chitosan has been researched along with Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, GY; Kim, HJ; Min, SK; Shim, KH; Shin, HS | 1 |
| Ding, Y; Ge, J; Li, L; Li, Y; Qiao, Y; Song, Y; Wang, M; Wen, A; Zhang, H; Zhang, Y | 1 |
2 other study(ies) available for chitosan and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Chitosan-coated C-phycocyanin Liposome for Extending the Neuroprotective Time Window Against Ischemic Brain Stroke.
Topics: Animals; Chitosan; Disease Models, Animal; Infarction, Middle Cerebral Artery; Liposomes; Neuroprotective Agents; Phycocyanin; Rats; Stroke | 2018 |
Enhanced Neuroprotection of Acetyl-11-Keto-β-Boswellic Acid (AKBA)-Loaded O-Carboxymethyl Chitosan Nanoparticles Through Antioxidant and Anti-Inflammatory Pathways.
Topics: Administration, Intravenous; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cells, Cultured; Chitosan; Disease Models, Animal; Glucose; Glutathione Peroxidase; Infarction, Middle Cerebral Artery; Interleukin-1beta; L-Lactate Dehydrogenase; Nanoparticles; Neurons; Neuroprotection; Neuroprotective Agents; Oxygen; Rats, Sprague-Dawley; Superoxide Dismutase; Tissue Distribution; Triterpenes; Tumor Necrosis Factor-alpha | 2016 |